M&T Bank Corp lowered its position in athenahealth, Inc (NASDAQ:ATHN) by 15.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,225 shares of the health services provider’s stock after selling 591 shares during the period. M&T Bank Corp’s holdings in athenahealth were worth $429,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also recently made changes to their positions in the company. The Manufacturers Life Insurance Company lifted its position in athenahealth by 7.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after purchasing an additional 84 shares during the period. Ameriprise Financial Inc. acquired a new stake in athenahealth in the second quarter valued at about $206,000. Lakeview Capital Partners LLC acquired a new stake in athenahealth in the fourth quarter valued at about $295,000. Quantbot Technologies LP acquired a new stake in athenahealth in the third quarter valued at about $337,000. Finally, State of Alaska Department of Revenue acquired a new stake in athenahealth in the fourth quarter valued at about $385,000.
Shares of athenahealth, Inc (NASDAQ ATHN) opened at $138.22 on Friday. athenahealth, Inc has a 12-month low of $95.01 and a 12-month high of $158.66. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.84 and a current ratio of 1.84. The stock has a market cap of $5,488.19, a P/E ratio of 80.99, a PEG ratio of 2.63 and a beta of 1.35.
athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.11 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.48. athenahealth had a net margin of 4.35% and a return on equity of 9.21%. The business had revenue of $329.20 million during the quarter, compared to analysts’ expectations of $319.64 million. During the same period last year, the company posted $0.62 EPS. The company’s revenue was up 14.2% on a year-over-year basis. sell-side analysts anticipate that athenahealth, Inc will post 2.51 earnings per share for the current year.
In other athenahealth news, Director Jeffrey R. Immelt acquired 7,200 shares of the company’s stock in a transaction dated Tuesday, February 20th. The stock was acquired at an average cost of $138.44 per share, with a total value of $996,768.00. Following the purchase, the director now directly owns 678 shares in the company, valued at approximately $93,862.32. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Jonathan Bush sold 30,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 26th. The stock was sold at an average price of $134.80, for a total transaction of $4,044,000.00. Following the transaction, the chief executive officer now directly owns 320,807 shares of the company’s stock, valued at $43,244,783.60. The disclosure for this sale can be found here. Over the last three months, insiders have sold 97,903 shares of company stock valued at $13,383,150. Corporate insiders own 3.20% of the company’s stock.
A number of brokerages recently commented on ATHN. BidaskClub upgraded shares of athenahealth from a “strong sell” rating to a “sell” rating in a research report on Saturday, February 17th. Piper Jaffray Companies restated a “buy” rating and issued a $160.00 price objective on shares of athenahealth in a research report on Friday, February 16th. Royal Bank of Canada set a $141.00 price objective on shares of athenahealth and gave the company a “hold” rating in a research report on Thursday, February 15th. SunTrust Banks raised their price objective on shares of athenahealth to $180.00 and gave the company a “buy” rating in a research report on Monday, February 5th. Finally, ValuEngine downgraded shares of athenahealth from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. Three equities research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and seven have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $144.23.
TRADEMARK VIOLATION WARNING: “athenahealth, Inc (ATHN) Position Reduced by M&T Bank Corp” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/23/athenahealth-inc-athn-position-reduced-by-mt-bank-corp.html.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc (NASDAQ:ATHN).
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.